Rabies immune globulin (human)
ایمونوگلوبولین هاری (HRIG)
🦠 Antiinfectives For Systemic UseSpecific immune globulin
Market / country: 🇺🇸 USA🇮🇷 Iran
HyperRAB (US)
🧮 Dose calculator
Rabies post-exposure prophylaxis (animal bite) · Regimen source: FDA HyperRAB · 2.1
- • Only for previously unvaccinated people, together with vaccine (day 0, no later than day 7). Infiltrate as much as possible into and around the wound; the rest IM away from the vaccine site. Do not exceed the dose (it blunts the vaccine response). FDA HyperRAB · 2.1FDA HyperRAB · 2.3
Enter age and weight.
🛡️ Safety & information
Formulations
- 300 IU/mL (1, 3, 5 mL vials) — injection 🇺🇸 USA FDA HyperRAB · 3
- 150 IU/mL (older/other products, e.g. sold in Iran) — check the vial strength — injection 🇮🇷 Iran FDA HyperRAB · 2.2Darooyab · G-3504/Rabies-Immunoglobulins
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA HyperRAB · 8.1
“Risk Summary There are no data with HYPERRAB use in pregnant women to inform a drug-associated risk.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA HyperRAB · 8.2
“Risk Summary There is no information regarding the presence of HYPERRAB in human milk, the effect on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA HyperRAB · 8.4
“Safety and effectiveness in the pediatric population have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA HyperRAB · 8.5
“Safety and effectiveness in geriatric population have not been established.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA101144
- DailyMed (FDA label)FDA HyperRAB
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDJ06BB05
- Darooyab (Iran)Rabies-Immunoglobulins
🇮🇷 Registered in Iran Darooyab · G-3504/Rabies-Immunoglobulins
Dosage forms with Iranian generic codes, per Darooyab.
- 01092 · RABIES IMMUNE GLOBULIN 300U VIAL · ویال هاری ایمونوگلوبولین ۳۰۰ واحد
- 01945 · RABIES IMMUNE GLOBULIN FROM PLASMA INF · محلول انفوزیون هاری ایمونوگلوبولین فروم پلاسما
- 50927 · RABIES IMMUNE GLOBULIN INJECTION PARENTERAL 150 [iU]/1mL 5 mL · فرآورده تزریقی هاری ایمونوگلوبولین ۱۵۰ واحد بینالمللی / ۱ میلیلیتر ۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA HyperRAB · 3FDA HyperRAB · 2.2FDA HyperRAB · 2.1FDA HyperRAB · 2.3FDA HyperRAB · 8.1FDA HyperRAB · 8.2FDA HyperRAB · 8.4FDA HyperRAB · 8.5FDA HyperRAB · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3504/Rabies-Immunoglobulins
- Clinical review⚠ Unverified